← Back to Search

Polyphenols

Blueberries for Metabolic Syndrome

N/A
Waitlist Available
Led By Marie-Claude Vohl
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least one of the following: BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6 months
Awards & highlights

Study Summary

This trial will study whether blueberries can help prevent obesity-linked metabolic syndrome by looking at the microbes in the gut and the metabolites produced.

Who is the study for?
This trial is for Caucasian men and premenopausal women in good health, with a BMI of 25-40 or waist circumference over 80 cm for women and 94 cm for men. Participants must have high triglycerides or fasting insulin levels. Exclusions include heavy drinkers, recent surgery or antibiotic use, smokers, certain medication users, metabolic disorder sufferers, blueberry allergies/intolerances, significant weight change recently, or special diets.Check my eligibility
What is being tested?
The study tests if daily consumption of either real blueberry powder or a placebo affects the gut microbiota and can help prevent obesity-related metabolic syndrome. It combines genetic material analysis (metagenomics), gene expression profiling (transcriptomics), and small molecule characterization (metabolomics) to understand how blueberries might benefit heart and metabolic health.See study design
What are the potential side effects?
Since this trial involves consuming blueberry powder which is generally considered safe as part of a regular diet; no significant side effects are expected beyond potential allergic reactions in those sensitive to blueberries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is between 25 and 40, or my waist size meets the criteria.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucose
Changes in plasma lipids/lipoproteins of overweight/obese men and women taking either blueberry powder or placebo blueberry powder
Secondary outcome measures
Changes in blood pressure of overweight/obese men and women taking either blueberry powder or placebo blueberry powder
Changes in gene expression in overweight/obese men and women taking either blueberry powder or placebo blueberry powder
Changes in inflammation biomarkers of overweight/obese men and women taking either blueberry powder or placebo blueberry powder
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Blueberry powderExperimental Treatment1 Intervention
Group II: Blueberry placebo powderPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,213 Total Patients Enrolled
26 Trials studying Metabolic Syndrome
1,976 Patients Enrolled for Metabolic Syndrome
Marie-Claude VohlPrincipal InvestigatorLaval University
3 Previous Clinical Trials
123 Total Patients Enrolled
2 Trials studying Metabolic Syndrome
100 Patients Enrolled for Metabolic Syndrome

Media Library

Blueberry Powder (Polyphenols) Clinical Trial Eligibility Overview. Trial Name: NCT03266055 — N/A
Metabolic Syndrome Research Study Groups: Blueberry powder, Blueberry placebo powder
Metabolic Syndrome Clinical Trial 2023: Blueberry Powder Highlights & Side Effects. Trial Name: NCT03266055 — N/A
Blueberry Powder (Polyphenols) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03266055 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities available for individuals to take part in this research project?

"The clinicaltrials.gov database indicates that this medical trial is not presently accepting patients, despite its inaugural posting on September 1st 2017 and last edit occurring on September 6th 2022. However, there are currently 1482 other studies actively recruiting individuals for their research projects."

Answered by AI

Is the elderly population being considered for participation in this clinical investigation?

"The inclusion parameters of this research require potential participants to be aged 18-55. In comparison, there are 384 studies that accept minors and 1053 trials for those over senior age."

Answered by AI

In which patient population is this experimental protocol open to enrollment?

"59 individuals, ranging in age from 18 to 55 and diagnosed with metabolic syndrome, are eligible for this study. Additional requirements include that applicants be male or premenopausal female of good health status; further, they must have either a Body Mass Index (BMI) between 25 kg/m2 and 40 kg/m2 or a waist circumference above 80 cm (women) or 94 cm (men)."

Answered by AI
~8 spots leftby Apr 2025